Intercellular adhesion molecule 1
|
Icam1 |
P13597 |
Multiple Sclerosis
|
Verity, D. H. et al. (Eur J Immunogenet, 2000), Marrosu, M. G. et al. (J Neurol, 2000), Nejentsev, S. et al. (Hum Immunol, 2003), Giorelli, M. et al. (Cell Commun Adhes, 2002), Cournu-Rebeix, I. et al. (Genes Immun, 2003), Mousavi, S. A. et al. (Eur J Neurol, 2007), Mitosek-Szewczyk, K. et al. (Acta Neurol Scand, 2010), Bullard, D. C. et al. (Eur J Immunol, 2014), Shawkatova, I. et al. (Folia Microbiol (Praha), 2017), Mix, E. et al. (J Neuroimmunol, 1994), Mycko, M. P. et al. (Ann Neurol, 1998)
|
Intercellular adhesion molecule 1
|
Icam1 |
Q00238 |
Multiple Sclerosis
|
Verity, D. H. et al. (Eur J Immunogenet, 2000), Marrosu, M. G. et al. (J Neurol, 2000), Nejentsev, S. et al. (Hum Immunol, 2003), Giorelli, M. et al. (Cell Commun Adhes, 2002), Cournu-Rebeix, I. et al. (Genes Immun, 2003), Mousavi, S. A. et al. (Eur J Neurol, 2007), Mitosek-Szewczyk, K. et al. (Acta Neurol Scand, 2010), Bullard, D. C. et al. (Eur J Immunol, 2014), Shawkatova, I. et al. (Folia Microbiol (Praha), 2017), Mix, E. et al. (J Neuroimmunol, 1994), Mycko, M. P. et al. (Ann Neurol, 1998)
|
Complement C2
|
C2 |
P21180 |
Multiple Sclerosis
|
Hafler, D. A. et al. (N Engl J Med, 2007)
|
Pleckstrin
|
Plek |
Q9JHK5 |
Multiple Sclerosis
|
Patsopoulos, N. A. et al. (Ann Neurol, 2011)
|
Monocyte differentiation antigen CD14
|
Cd14 |
P10810 |
Multiple Sclerosis
|
Brassat, D. et al. (Genes Immun, 2006), Lutterotti, A. et al. (J Neuroimmunol, 2006), Kurne, A. et al. (J Neuroimmunol, 2012), Lopez-Gomez, C. et al. (J Neurol Neurosurg Psychiatry, 2016)
|
Growth-regulated alpha protein
|
Cxcl1 |
P12850 |
Multiple Sclerosis
|
Rubio, N. et al. (Virology, 2007)
|
Growth-regulated alpha protein
|
Cxcl1 |
P14095 |
Multiple Sclerosis
|
Rubio, N. et al. (Virology, 2007)
|
2',3'-cyclic-nucleotide 3'-phosphodiesterase
|
Cnp |
P13233 |
Multiple Sclerosis
|
|
Polyubiquitin-C
|
Ubc |
Q63429 |
Multiple Sclerosis
|
Mahurkar, S. et al. (PLoS One, 2013)
|
C-C motif chemokine 3
|
Ccl3 |
P10855 |
Multiple Sclerosis
|
|
C-C motif chemokine 2
|
Ccl2 |
P10148 |
Multiple Sclerosis
|
Iarlori, C. et al. (J Neuroimmunol, 2002), Huang, D. et al. (J Neurosci, 2002), Dawson, J. et al. (Expert Opin Ther Targets, 2003), Miyagishi, R. et al. (J Neuroimmunol, 2003), Sorensen, T. L. et al. (Eur J Neurol, 2004), Huang, D. et al. (FASEB J, 2005), Mohan, H. et al. (Brain Pathol, 2010), Sanseverino, I. et al. (J Steroid Biochem Mol Biol, 2014), Kooij, G. et al. (Acta Neuropathol, 2014), Simpson, J. E. et al. (J Neuroimmunol, 1998), McManus, C. et al. (J Neuroimmunol, 1998), Kivisakk, P. et al. (J Neuroimmunol, 1998)
|
Oncostatin-M
|
Osm |
Q65Z15 |
Multiple Sclerosis
|
Ruprecht, K. et al. (J Neuropathol Exp Neurol, 2001), Repovic, P. et al. (Glia, 2003)
|
Glial fibrillary acidic protein
|
Gfap |
P03995 |
Multiple Sclerosis
|
Haghighi, S. et al. (Acta Neurol Scand, 2004), Raijmakers, R. et al. (J Comp Neurol, 2006), Mastronardi, F. G. et al. (J Neurosci, 2006), Koning, N. et al. (Ann Neurol, 2007), Matsuoka, T. et al. (Brain Pathol, 2011), Smolders, J. et al. (J Neuropathol Exp Neurol, 2013), Bradford, C. M. et al. (J Neuroimmunol, 2014), De Groot, C. J. et al. (J Neuropathol Exp Neurol, 1997)
|
Matrix metalloproteinase-9
|
Mmp9 |
P41245 |
Multiple Sclerosis
|
Ozenci, V. et al. (J Autoimmun, 1999), Lichtinghagen, R. et al. (J Neuroimmunol, 1999), Sellebjerg, F. et al. (J Neuroimmunol, 2000), Nelissen, I. et al. (J Neuroimmunol, 2000), Liuzzi, G. M. et al. (J Neurovirol, 2000), Kouwenhoven, M. et al. (J Neuroimmunol, 2002), Sellebjerg, F. et al. (Brain Res Bull, 2003), Starckx, S. et al. (J Neuroimmunol, 2003), Gilli, F. et al. (Brain, 2004), Opdenakker, G. et al. (Lancet Neurol, 2003), Fiotti, N. et al. (J Neuroimmunol, 2004), Blanco, Y. et al. (J Neuroimmunol, 2004), Avolio, C. et al. (Mult Scler, 2005), Tanuma, N. et al. (Acta Neuropathol, 2006), Zivkovic, M. et al. (J Neuroimmunol, 2007), Garcia-Montojo, M. et al. (J Neurovirol, 2007), Gray, E. et al. (J Neuropathol Exp Neurol, 2008), Benesova, Y. et al. (J Neuroimmunol, 2008), Bernal, F. et al. (Mult Scler, 2009), Mirowska-Guzel, D. et al. (J Neuroimmunol, 2009), Fernandes, K. S. et al. (J Neuroimmunol, 2009), La Russa, A. et al. (J Neuroimmunol, 2010), Fernandes, K. S. et al. (J Neuroimmunol, 2012), Cox, M. B. et al. (Mult Scler, 2014), Rossano, R. et al. (J Cell Mol Med, 2014), Aung, L. L. et al. (J Neuroimmunol, 2015), Nischwitz, S. et al. (J Neuroimmunol, 2015), Gasparovic, I. et al. (J Neuroimmunol, 2015), Cuzner, M. L. et al. (J Neuropathol Exp Neurol, 1996)
|
Arylsulfatase A
|
Arsa |
P50428 |
Multiple Sclerosis
|
Kappler, J. et al. (Dev Neurosci, 1991)
|
Metalloproteinase inhibitor 2
|
Timp2 |
P25785 |
Multiple Sclerosis
|
Ozenci, V. et al. (J Autoimmun, 1999), Lichtinghagen, R. et al. (J Neuroimmunol, 1999), Kouwenhoven, M. et al. (J Neuroimmunol, 2002), Galboiz, Y. et al. (J Neuroimmunol, 2002), Avolio, C. et al. (Mult Scler, 2005)
|
Metalloproteinase inhibitor 2
|
Timp2 |
P30121 |
Multiple Sclerosis
|
Ozenci, V. et al. (J Autoimmun, 1999), Lichtinghagen, R. et al. (J Neuroimmunol, 1999), Kouwenhoven, M. et al. (J Neuroimmunol, 2002), Galboiz, Y. et al. (J Neuroimmunol, 2002), Avolio, C. et al. (Mult Scler, 2005)
|
Interleukin-1 receptor antagonist protein
|
Il1rn |
P25085 |
Multiple Sclerosis
|
Sciacca, F. L. et al. (Neurology, 1999), Heesen, C. et al. (Acta Neurol Scand, 2000), Feakes, R. et al. (J Neuroimmunol, 2000), Sciacca, F. L. et al. (J Neurovirol, 2000), Niino, M. et al. (J Neuroimmunol, 2001), de Jong, B. A. et al. (J Neuroimmunol, 2002), Schrijver, H. M. et al. (Mediators Inflamm, 2003), Hooper-van Veen, T. et al. (Mult Scler, 2003), Dincic, E. et al. (J Neuroimmunol, 2006), Borzani, I. et al. (Eur J Neurol, 2010), Mirowska-Guzel, D. et al. (J Neuroimmunol, 2011), Huang, J. et al. (Inflamm Res, 2013), Peelen, E. et al. (Mol Immunol, 2015), Wansen, K. et al. (J Neuroimmunol, 1997), de la Concha, E. G. et al. (J Neuroimmunol, 1997)
|
Interleukin-1 receptor antagonist protein
|
Il1rn |
P25086 |
Multiple Sclerosis
|
Sciacca, F. L. et al. (Neurology, 1999), Heesen, C. et al. (Acta Neurol Scand, 2000), Feakes, R. et al. (J Neuroimmunol, 2000), Sciacca, F. L. et al. (J Neurovirol, 2000), Niino, M. et al. (J Neuroimmunol, 2001), de Jong, B. A. et al. (J Neuroimmunol, 2002), Schrijver, H. M. et al. (Mediators Inflamm, 2003), Hooper-van Veen, T. et al. (Mult Scler, 2003), Dincic, E. et al. (J Neuroimmunol, 2006), Borzani, I. et al. (Eur J Neurol, 2010), Mirowska-Guzel, D. et al. (J Neuroimmunol, 2011), Huang, J. et al. (Inflamm Res, 2013), Peelen, E. et al. (Mol Immunol, 2015), Wansen, K. et al. (J Neuroimmunol, 1997), de la Concha, E. G. et al. (J Neuroimmunol, 1997)
|
Vascular cell adhesion protein 1
|
Vcam1 |
P29533 |
Multiple Sclerosis
|
Mitosek-Szewczyk, K. et al. (Acta Neurol Scand, 2010), Nishihara, H. et al. (PLoS One, 2015)
|
C-X-C motif chemokine 2
|
Cxcl2 |
P30348 |
Multiple Sclerosis
|
Barthelmes, J. et al. (Brain Behav Immun, 2015)
|
Follistatin
|
Fst |
P21674 |
Multiple Sclerosis
|
Michel, U. et al. (Eur J Endocrinol, 2000)
|
Follistatin
|
Fst |
P47931 |
Multiple Sclerosis
|
Michel, U. et al. (Eur J Endocrinol, 2000)
|
Interleukin-10
|
Il10 |
P29456 |
Multiple Sclerosis
|
van Boxel-Dezaire, A. H. et al. (Ann Neurol, 1999), Kivisakk, P. et al. (Acta Neurol Scand, 1999), Pickard, C. et al. (J Neuroimmunol, 1999), Maurer, M. et al. (J Neuroimmunol, 2000), Vandenbark, A. A. et al. (J Neurosci Res, 2001), Almeras, L. et al. (Eur Cytokine Netw, 2002), Beebe, A. M. et al. (Cytokine Growth Factor Rev, 2002), Martinez Doncel, A. et al. (J Neuroimmunol, 2002), Luomala, M. et al. (Acta Neurol Scand, 2003), Wergeland, S. et al. (Eur J Neurol, 2005), Mihailova, S. et al. (J Neuroimmunol, 2005), Astier, A. L. et al. (J Clin Invest, 2006), Castelli, L. et al. (J Neuroimmunol, 2007), Zeis, T. et al. (Brain, 2008), Martinez-Forero, I. et al. (Eur J Immunol, 2008), Krakauer, M. et al. (Mult Scler, 2008), Sellner, J. et al. (Neurochem Int, 2008), Ma, A. et al. (Int Immunopharmacol, 2009), Hesse, D. et al. (Eur J Neurol, 2011), Mirowska-Guzel, D. et al. (J Neuroimmunol, 2011), Annunziata, P. et al. (J Neuroimmunol, 2013), Peelen, E. et al. (J Neuroimmunol, 2013), Simpson, S. Jr et al. (J Neurol Neurosurg Psychiatry, 2015), Liao, W. et al. (Biomaterials, 2016), Ben Fredj, N. et al. (APMIS, 2017), Ramakrishnan, V. et al. (J Neuroimmunol, 2017), Shahbazi, M. et al. (Indian J Med Res, 2017), Byskosh, P. V. et al. (Mult Scler, 1996), Monteyne, P. et al. (J Neuroimmunol, 1997), Gayo, A. et al. (J Neuroimmunol, 1998)
|
MHC class II regulatory factor RFX1
|
Rfx1 |
P48377 |
Multiple Sclerosis
|
Gobin, S. J. et al. (Glia, 2001)
|